Announced Insider Trading

Published: 2024-11-19

Dr. Michael Diefenbeck, Chief Medical Officer and EVP Clinical Affairs, has sold 30,000 shares, with the sole purpose to cover tax effects of the distributed shares from the employee 2016 stock options program. After the transaction, his total ownership of shares in BONESUPPORT™ has increased with 24,000 shares to 108,160.